Pathophysiology and treatment of fatigue in multiple sclerosis
D Boerio, JP Lefaucheur, JY Hogrel… - Revue …, 2006 - europepmc.org
Patients suffering from multiple sclerosis (MS) frequently complain of fatigue (53 to 92
percent depending on studies). Fatigue can be one of the most disabling symptoms of MS …
percent depending on studies). Fatigue can be one of the most disabling symptoms of MS …
Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options–Review Article
D Zimek, M Miklusova, J Mares - Neuropsychiatric Disease and …, 2023 - Taylor & Francis
Fatigue is a common, debilitating and often underestimated symptom in patients with
multiple sclerosis (MS). The exact pathophysiological mechanism of fatigue in MS is still …
multiple sclerosis (MS). The exact pathophysiological mechanism of fatigue in MS is still …
Pathophysiology, assessment and management of multiple sclerosis fatigue: an update
M Rottoli, S La Gioia, B Frigeni… - Expert review of …, 2017 - Taylor & Francis
Introduction: Fatigue is one of the most common symptoms associated with multiple
sclerosis, affecting almost 80% of patients with 55% of them reporting it as one of the worst …
sclerosis, affecting almost 80% of patients with 55% of them reporting it as one of the worst …
Management of fatigue in multiple sclerosis
A Pappalardo, E Reggio, F Patti… - European Journal of …, 2003 - search.proquest.com
Fatigue is one of the most common disabling symptoms in patients with multiple sclerosis
(MS). It is considered a condition characterized by sense of exhaustion distinct from …
(MS). It is considered a condition characterized by sense of exhaustion distinct from …
[HTML][HTML] Fatigue in multiple sclerosis: a diagnostic and therapeutic challenge
F Paul, C Veauthier - Expert Opinion on Pharmacotherapy, 2012 - Taylor & Francis
Multiple sclerosis (MS) is the most frequent autoimmune CNS condition in young adults in
Western countries. It leads to demyelination and neuroaxonal damage. Classic neurological …
Western countries. It leads to demyelination and neuroaxonal damage. Classic neurological …
Fatigue in multiple sclerosis
Background: Fatigue is the most commonly reported symptom in multiple sclerosis (MS).
Purpose: This brief narrative review addresses the clinical features, pathophysiology, and …
Purpose: This brief narrative review addresses the clinical features, pathophysiology, and …
Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors
J lriarte, ML Subirá, P de Castro - Multiple Sclerosis Journal, 2000 - journals.sagepub.com
Although different factors are probably involved in the etiology of fatigue in multiple sclerosis
patient, no definite mechanism has been proposed. We have proposed that fatigue is a …
patient, no definite mechanism has been proposed. We have proposed that fatigue is a …
Physiopathology of fatigue in multiple sclerosis
L Leocani, B Colombo, G Comi - Neurological Sciences, 2008 - Springer
Fatigue is an overwhelming sense of tiredness or lack of energy, affecting both mental and
physical domains. Fatigue is reported by about 50% of patients with multiple sclerosis (MS) …
physical domains. Fatigue is reported by about 50% of patients with multiple sclerosis (MS) …
Fatigue in multiple sclerosis
E Dworzańska, K Mitosek-Szewczyk… - … i Neurochirurgia Polska, 2009 - europepmc.org
Fatigue is one of the most common symptoms of multiple sclerosis (MS) and is associated
with reduced quality of life. The fatigue syndrome is characterized by uncontrollable apathy …
with reduced quality of life. The fatigue syndrome is characterized by uncontrollable apathy …
[HTML][HTML] New strategies for rehabilitation and pharmacological treatment of fatigue syndrome in multiple sclerosis
E Zielińska-Nowak, L Włodarczyk, J Kostka… - Journal of clinical …, 2020 - mdpi.com
Multiple sclerosis (MS) is the most common autoimmune disease of the central nervous
system (CNS), with an inflammatory demyelinating basis and a progressive course. The …
system (CNS), with an inflammatory demyelinating basis and a progressive course. The …